ATC Group: D01A Antifungals for topical use

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01A in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01A Antifungals for topical use

Group D01A contents

Code Title
D01AA Antibiotics
D01AC Imidazole and triazole derivatives
D01AE Other antifungals for topical use

Active ingredients in D01A

Active Ingredient

Amorolfine is a broad spectrum antimycotic. Amorolfine belongs to a new chemical class, and its fungicidal action is based on an alteration of the fungal cell membrane targeted primarily on sterol biosynthesis. The ergosterol content is reduced, and at the same time unusual sterically nonplanar sterols accumulate.

Bifonazole is an imidazole derivative with a broad antimycotic spectrum, which includes dermatophytes, yeasts, moulds and other fungi such as Malassezia furfur. It is also effective against Corynebacterium minutissimum.

Butenafine is a benzylamine derivative with a mode of action similar to that of the allylamine class of antifungal drugs. Butenafine HCl is hypothesized to act by inhibiting the epoxidation of squalene, thus blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes. It is indicated for the topical treatment of the dermatologic infection, tinea (pityriasis) versicolor due to M. furfur (formerly P. orbiculare).

Ciclopirox is a hydroxypyridone antifungal agent which is active in vitro inhibiting the growth of various fungal species including the yeast Malassezia furfur (formerly known as Pityrosporum ovale or Pityrosporum orbiculare).

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

Econazole nitrate is a broad spectrum antimycotic with activity against dermatophytes, yeasts and moulds. A clinically relevant action against Gram positive bacteria has also been found.

Efinaconazole is an azole antifungal used for the topical treatment of onychomycosis.

Fenticonazole is a broad-spectrum antimycotic agent.

Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.

Flucytosine is a fluorinated pyrimidine derivative. It is an antimycotic agent exerting fungistatic and fungicidal activity by interfering with protein and DNA synthesis. Fluorodeoxyuridine interferes with the enzyme thymidylate synthase. Inhibition of thymidylate synthase subsequently causes disruption of DNA synthesis.

Isoconazole is for use in the treatment of superficial fungal diseases of the skin. It displays a very broad spectrum of antimicrobial action. It is effective against dermatophytes and yeasts, yeast-like fungi (including the causative organism of pityriasis versicolor) and molds, as well against gram-positive bacteria in-vitro and against the causative organism of erythrasma.

Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes.

Luliconazole is an azole antifungal. At therapeutic doses, luliconazole cream, is not expected to prolong QTc to any clinically relevant extent. It is used for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.

Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis.

Naftifine is a topical antifungal drug. it is used for the the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.

Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis. It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium. The mechanism of action appears to be through binding of the molecule to the sterol moiety of the fungal cell membrane.

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.

Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.

Sertaconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. This enzyme functions to convert lanosterol to ergosterol. Ergosterol is a key component of fungal cell membranes and lack of this component leads to fungal cell injury by leakage of key constituents in the cytoplasm from the cell.

Sulconazole is an imidazole derivative with broad-spectrum antifungal activity that inhibits the growth in vitro of the common pathogenic dermatophytes. It also inhibits (in vitro) the organism responsible for tinea versicolor, Malassezia furfur, and has been shown to be active against Candida albicans.

Tavaborole is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.

Terbinafine is an allylamine which has a broad spectrum of antifungal activity. Terbinafine acts by inhibition of squalene epoxidase in the fungal cell membrane. At low concentrations terbinafine is fungicidal against dermatophytes, moulds and certain dimorphic fungi. The activity versus yeasts is fungicidal or fungistatic depending on the species.

Tioconazole is an imidazole derivative. Tioconazole is a broad spectrum antifungal agent that also has an antibacterial effect on a number of Gram-positive cocci (e.g. Stapphylococcus, Streptococcus species). It is active against commonly occurring dermatophyte and yeast-like fungal species.

Related product monographs

Document Type Information Source  
 CANDIPLAS Cream MPI, EU: SmPC Υπουργείο Υγείας (CY)
 CANDIPLAS H Cream MPI, EU: SmPC Υπουργείο Υγείας (CY)
 CANESPOR Cream MPI, EU: SmPC Health Products Regulatory Authority (IE)
 CANESTEN BIFONAZOLE ONCE DAILY Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 CANESTEN THRUSH INTERNAL CREAM 10% w/w Vaginal cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 CLOMAZOL Vaginal cream MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 CLOTRIMADERM Vaginal cream MPI, CA: SPM Health Products and Food Branch (CA)
 CURANAIL Medicated nail lacquer MPI, EU: SmPC Health Products Regulatory Authority (IE)
 DAKTACORT Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAKTARIN Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAKTARIN INTENSIV Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAKTARIN Oral gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ERTACZO Cream MPI, US: SPL/PLR FDA, National Drug Code (US)
 EXELDERM Cream, 1.0% MPI, US: SPL/Old FDA, National Drug Code (US)
 GRISOL Cutaneous spray, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 GYNO-DAKTARIN Vaginal cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 JUBLIA Solution MPI, US: SPL/PLR FDA, National Drug Code (US)
 LAMISIL Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 LOCERYL Nail lacquer MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 LOMEXIN 2% Cream / Gel / Shampoo / Cutaneous solution / Cutaneous powder MPI, EU: SmPC Web Search
 LOPROX Cream MPI, US: SPL/Old FDA, National Drug Code (US)
 LOPROX Shampoo MPI, US: SPL/PLR FDA, National Drug Code (US)
 LOPROX Topical suspension MPI, US: SPL/Old FDA, National Drug Code (US)
 LOTRIDERM Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 LOTRISONE Cream MPI, US: SPL/PLR FDA, National Drug Code (US)
 MENTAX Cream MPI, US: SPL/Old FDA, National Drug Code (US)
 MYCORIL Vaginal tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 NIZORAL Shampoo MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 OCCLUSAL Cutaneous solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ONYTEC Medicated nail lacquer MPI, EU: SmPC Health Products Regulatory Authority (IE)
 PENLAC Nail lacquer MPI, US: SPL/Old FDA, National Drug Code (US)
 PEVARYL Topical cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SELSUN Shampoo MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 STIEPROX Shampoo MPI, EU: SmPC Health Products Regulatory Authority (IE)
 TEFIN Suppository MPI, EU: SmPC Health Products Regulatory Authority (IE)
 TINADERM Cream MPI, EU: SmPC Health Products Regulatory Authority (IE)
 TRAVOCORT Cream MPI, EU: SmPC Health Products Regulatory Authority (IE)
 TROSYL Nail solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 VERRUGON Ointment MPI, EU: SmPC Health Products Regulatory Authority (IE)
 WARTEX Ointment MPI, EU: SmPC Health Products Regulatory Authority (IE)